Importantly, we demonstrate that exogenous application of CGRP can accelerate bone formation in aged and OVX mice in vivo, implying that CGRP may be a potential therapeutic target for the prevention of osteoporosis. The gene discussed is CALCA; the disease is osteoporosis.